The Three Numbers That Decide If a Pharmacy Service Survives

Contributed by Blair Thielemier, PharmD, Pharmacy Customer Success, PQS by Innovaccer Pharmacists have always known where the gaps are. They solve medication-related problems every day in the dispensing workflow. They identify gaps in therapy and assist in navigating multiple providers for each patient. They know their patients well enough to recognize when someone is confused, […]

What Is The Next Great Stewardship Opportunity For Pharmacists?

By Darren Triller, PharmD Which medication class leads to the highest number of emergency department visits for adverse drug events (ADEs) in the U.S.? Many pharmacists would guess antibiotics. Antimicrobial resistance has been recognized as a global public health threat for years, and antimicrobial stewardship programs are now a standard component of healthcare delivery. Others […]

Ready for 2027: What 340B Covered Entities Need to Know Now

January developments could affect reimbursement, cash flow, purchasing, and program operations. The time to understand the exposure is now. By Katy Lees Four operational and financial changes could reach 340B covered entities on January 1, 2027. They include a proposed change to Medicare reimbursement for 340B-acquired drugs, a revised federal 340B rebate model pilot, an […]

Inside Thundermist: How This FQHC Delivers Comprehensive, Community- Rooted Care

Inside Thundermist: How This FQHC Delivers Comprehensive, Community- Rooted Care

Written by Joshua Murdock, PharmD, BCBBS Thundermist Health Center doesn’t look like a typical health clinic. It feels like a small health system. In addition to its primary care services, this federally qualified health center (FQHC) offers substance usedisorder treatment, HIV care through the Ryan White HIV/AIDS Program, a dental practice, mobile medical units, and […]

Brian Litten on Making AssureCare Impossible to Ignore: An RXinsider Interview

By Joshua Murdock, PharmD, BCBBS AssureCare is an AI-powered population health management company whose platform spans payers, providers, and pharmacies; it’s built around whole-person care. The company recently brought in a new executive to help grow the platform’s reach. In August 2026, Brian Litten was named Executive Vice President (EVP) of Growth and Commercialization at […]

Natasha Baria Mehta Talks ACU-Serve’s Path to a Scalable Platform: An RXinsider Interview

Written by Joshua Murdock, PharmD, BCBBS ACU-Serve is a revenue cycle management company serving providers across post-acute care segments. Founded in 1993, the company has built its reputation on deep, specialized knowledge of a highly regulated niche.  Natasha Baria Mehta was named President of ACU-Serve in May 2026, bringing more than 25 years of revenue […]

Meet Hal: How AI Automation Is Helping One Pharmacy Team Work Smarter, Not Harder

By Megan McCaskill, RPh, President of Compliance and Strategy at Horizon Pharmacy AI is quickly reshaping pharmacy operations. It can now help pharmacy teams work smarter by taking on repetitive, time-consuming tasks, freeing employees to focus on work that requires human judgment and meaningful communication. At Horizon Pharmacy, AI has moved from concept to practice […]

Nnamdi Njoku on Omnicell’s Next Chapter: An RXinsider Interview

Written by Joshua Murdock, PharmD, BCBBS Nnamdi Njoku was named President of Omnicell in July 2026, adding the title to his existing role as chief operating officer (COO).  In this exclusive interview with RXinsider, Njoku discusses the priorities shaping Omnicell’s roadmap, including the OmniSphere cloud platform and Titan XT automated dispensing system, and how they […]

Reflection on the Impact of the Inflation Reduction Act (IRA) Negotiated Drug Pricing

SME_340B

Contributed by SME, Steven Miller, 340B Health The Inflation Reduction Act (IRA) continues to reshape the Medicare prescription drug landscape through the implementation of the Medicare Drug Price Negotiation Program. On January 1, 2026, negotiated Maximum Fair Prices (MFPs) took effect for the first 10 Medicare Part D drugs selected by the Centers for Medicare […]

Beyond Clinical Trials: Why Medical Affairs Matters in Compounding Pharmacy

Contributed by SME: Jean Cunningham, PharmD, BCPS, Senior Director of Medical Affairs, Empower Pharmacy In healthcare, randomized controlled trials remain the gold standard for evaluating safety and efficacy. Pharmacists and other healthcare professionals should continue to advocate for high-quality evidence whenever possible. However, those who work in compounding pharmacy face an often-overlooked reality. The evidence […]

SUBSCRIBE

Name
Subscription Choices
Checkboxes
Subscribe
Receive the latest news, product launches, and insights from RXinsider.

Request information from Beyond Clinical Trials: Why Medical Affairs Matters in Compounding Pharmacy

Name
Address
Subscribe